IL‐2‐Fc and ICK caused significant decreases in circulating CD4+ T cells in both models (Figure 2M; Figure S4M), although no significant changes in circulating Tregs were observed in both models (Figure 2N; Figure S4N), suggesting changes in circulating T cell frequencies do not correlate with changes seen within the tumor. The gene discussed is IL2; the disease is neoplasm.